Hearing aid manufacturer Demant prepares for another economic blow. In 2019, the company was hit by a hacking attack that laid its operations low for several weeks. Then, the company was sent to its knees when the market froze over because of the Covid-19 pandemic.
After a functional error was discovered in a produt, Demant's subsidiary Oticon Medical announced on Thursday that it is withdrawing almost 4,000 non-implanted devices of its Neuro Zti product type. Additionally, the sales of said device have been stopped. Faulty devices will be removed from the 28 patients who have already had the cochlear device implanted.
Already a subscriber? Log in.
Read the whole article
Get 14 days free access.
No credit card required.
Get full access for you and your coworkers.Start a free company trial today
Your trial for MedWatch has now started
With your free trial you get:
Full access to all locked articles on MedWatch.
Daily newsletter and ongoing top-newsletters. You can unsubscribe and subscribe to our newsletters anytime.
When your trial period expires
You will not be transferred to a paid subscription.
You will continue to receive our newsletters after the trial period expires. You can unsubscribe at the bottom of each newsletter.